No Data
No Data
Kepler Capital Keeps Their Buy Rating on Roche Holding AG (RHHVF)
Roche Holding AG (RHHVF) Receives a Hold From Barclays
"Strong rivals" are coming one after the other. Eli Lilly and Co (LLY.US) has evaporated over 120 billion US dollars in market cap. Has the "Novartis duo" finally been broken?
Due to at least two competitors making encouraging progress in the treatment of obesity, Eli Lilly and Co.'s position as the leader in the weight-loss drug boom is being threatened, with market cap evaporating more than $120 billion in the past eight days.
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Edwards Lifesciences (EW)
AstraZeneca Slips Despite 2024 Guidance Raise on Medicines Demand
Viking Sends Lilly, Novo Lower as Obesity Drug Enters Late-stage Program
No Data